EVENTS & PRESENTATIONS

Upcoming Events

Date Details Remind Me
Sep 27, 2017

Cantor Fitzgerald Global Healthcare Conference

Archived Events

Date Details Remind Me
Mar 2, 2017

Chimerix Q4 2016 Earnings Conference Call

Nov 7, 2016

Chimerix Q3 2016 Earnings Conference Call

May 9, 2016

Chimerix Q1 2016 Earnings Conference Call

Feb 20, 2016

Presentation of Phase 3 SUPPRESS Detailed Results at BMT Tandem Meetings

Dec 28, 2015

Chimerix Corporate Update

Mar 7, 2017

Cowen and Company 37th Annual Health Care Conference

Jan 11, 2017

J.P. Morgan 35th Annual Healthcare Conference

Sep 12, 2016

Morgan Stanley Global Healthcare Conference

Feb 29, 2016

Chimerix Q4 2015 Earnings Conference Call

Feb 12, 2015

BMT Tandem Meeting Abstract Preliminary Results from the AdVise Study Evaluating Brincidofovir (BCV, CMX001) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection

Nov 5, 2015

Chimerix Q3 2015 Earnings Conference Call

Feb 23, 2017

Treatment of Adenovirus (ADV) Infection In Allogeneic Hematopoietic Cell Transplant Patients With Brincidofovir: Final 36 Week Results From The Advise Trial

Nov 15, 2016

Stifel 2016 Healthcare Conference

Aug 8, 2016

Chimerix Q2 2016 Earnings Conference Call

Feb 22, 2016

Corporate Update Call on SUPPRESS Results and Brincidofovir Program

Feb 12, 2015

BMT Tandem Meeting</br>Presentation Preliminary Results from the AdVise Study Evaluating Brincidofovir (BCV, CMX001) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection

Apr 27, 2017

Chimerix Annual Investor Update

Aug 7, 2017

Chimerix Q2 2017 Earnings Conference Call

May 9, 2017

Chimerix Q1 2017 Earnings Conference Call

Presentations